Bill Title: Providing for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2018-03-20 - Motion to reconsider laid on the table Agreed to without objection. [HR787 Detail]

Text: Latest bill text (Engrossed) [PDF]

---

Sponsors

Name	Type	Contact	Phone	District	Sponsorship	State Profile	Financial	Encyclopedia	Biography	BioGuide
Representative Michael Burgess [R]	Primary	N/A	N/A	HD-TX-26	Sponsored Bills	N/A	OpenSecrets	Ballotpedia	VoteSmart	BioGuide

Social Comments on US HR787